In high-glucose-injured HUVECs, Tβ4 did not alter the insulin-signaling pathway.
In plain wordsIn cells, Tβ4 did not change the insulin-signaling pathway.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- No significant changeInsulin-signaling pathway under high-glucose blockade
- Study
humann: not reported in source
High-glucose-injured HUVECs- Outcome group
- Receptor activity and mechanism · Cardiovascular
- Studied dose
- Dose not stated
Source sentences
Tβ4 did not alter the insulin-signaling pathway
1 context sentence(design, population, supporting numbers)
Thus, the aim of this study was to elucidate the role of Tβ4 in diabetes and the possible involvement of insulin-like growth factor-1 (IGF-1), which affects cellular survival, metabolism, and glucose homeostasis in high-glucose (HG)-injured human umbilical vein endothelial cells (HUVECs).